TruScreen to Present at Singapore Healthcare Day Forum
Marty Dillon, CEO of TruScreen is presenting the company’s innovative AI enabled cervical cancer screening technology at the Singapore Healthcare Day Forum
The Presentation focuses on the global recognition of the TruScreen tonology and of its successes to date for Low- and Middle-Income Countries
TruScreen Group Limited (“TruScreen” or “the Company”) advises that its CEO, Marty Dillon is an invited presenter at the Healthcare Day Forum held in Singapore on Monday March 24, 2025.
Mr Dillon’s presentation is attached for the information of stakeholders.
TruScreen CEO, Marty Dillon commented:
This invitation follows on from a watershed 2024 year where TruScreen received recognition for our cervical cancer screening technology from leading global organisations such as the World Health Organization, UNITAID, Chinese Obstetricians and Gynaecologists Association (COGA) and the Chinese Society of Colposcopy and Clinical Pathology (CSCCP). TruScreen is proud to be one of only six Australian medtech companies invited to showcase our innovative technology at this forum. TruScreen will continue to work with its global distributors to assist with achieving the WHO strategic objective of eliminating cervical cancer by the end of the century. Cervical cancer is the 4th highest cancer-causing deaths amongst women and accounts for in excess of 350,000 global deaths per annum in the past years.